Search

Your search keyword '"KAYMAKOĞLU, SABAHATTİN"' showing total 121 results

Search Constraints

Start Over You searched for: Author "KAYMAKOĞLU, SABAHATTİN" Remove constraint Author: "KAYMAKOĞLU, SABAHATTİN" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
121 results on '"KAYMAKOĞLU, SABAHATTİN"'

Search Results

1. CirrMRI600+: Large Scale MRI Collection and Segmentation of Cirrhotic Liver

2. Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report.

3. THU-171 Recurrence of primary sclerosing cholangitis after living donor liver transplantation: experience from turkish registry

4. WED-318-YI Steatotic liver disease in diabetic patients: more serious diabetes mellitus, more serious liver disease

7. The Consequences of HLA Screening in the Prevention of Graft‐Versus‐Host Disease in Living Donor Liver Transplantation.

8. Enhancing Diagnostic Yield of EUS-Guided FNA Through On-site Cytopathology.

12. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

13. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

14. Are the Clinical Course and Drug Toxicity Different in Late-Onset Inflammatory Bowel Disease Patients? From Tertiary Reference Center Real-Life Data.

15. Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational Study

22. Two Cases of Malignant Transformation in Crohn's Disease with Perianal Involvement.

23. Mucocutaneous manifestations and associated factors in patients with Crohn's disease

25. Evaluation of safety and efficacy of tenofovir disoproxil in hemodialysis and renal transplant patients monoinfected with hepatitis B virus based on real life data

27. Different Faces of Eosinophilic Infiltration of Gastrointestinal System.

30. Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience

31. SAT-485 - The liver worsens in non-alcoholic fatty liver disease patients as diabetes mellitus worsens and lasts longer

38. Evaluation of Histopathological Correspondence of Atrophic Gastritis Observed in Endoscopy: Systematic Review

40. Recommendation for treatment of hepatitis C virus infection

42. The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists

43. Is Tofacitinib an Option for Salvage Therapy in Acute Severe Ulcerative Colitis?

44. The COVID-19 pandemic: clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists

45. Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes?

46. Real world data on safety and efficacy of Ledipasvir Sofosbuvir ± RBV, Ombitasvir / Paritaprevir / Ritonavir ± Dasabuvir ± RBV combination therapy for chronic hepatitis C. A Turkey experience

48. Risk factors associated with progression to intestinal complications of Crohn disease

49. Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers

50. Current state and clinical outcome in Turkish patients with hepatocellular carcinoma

Catalog

Books, media, physical & digital resources